China’s grand ambition to eliminate psoriasis from a thousand counties
For global dermatologists and public-health strategists, this initiative offers a rare real-world laboratory in which a vast, heterogeneous population is being systematically connected to early intervention — with lessons that extend far beyond China’s borders.
Chinese scientists have unveiled a bold public-health framework aimed at transforming early psoriasis care across the nation’s most rural and underserved regions. The article, “Thousand counties, no psoriasis,” published in the Journal of Investigative Dermatology (May 2026) by authors Yu-Xin Zheng and Min Zheng, outlines a systematic pathway to bring dermatological screening and treatment to county-level populations that have historically lacked access to specialist care.
Psoriasis, a chronic inflammatory skin condition affecting roughly 0.5 to 1 percent of China’s population, imposes a significant burden on quality of life and is associated with comorbidities such as psoriatic arthritis and cardiovascular disease. The proposed “thousand counties” strategy is designed to bridge the gap between advanced urban dermatology centres and county hospitals, leveraging telehealth, standardised diagnostic protocols, and a tiered referral system. By embedding early detection within the existing primary-care infrastructure, the initiative seeks to reduce both the severity of disease progression and the long-term economic strain on the healthcare system.
What makes this effort noteworthy is its scale and ambition. China’s county-level hospitals serve hundreds of millions of people, many of whom currently receive a diagnosis only after the condition has become severe. The Zheng-Zheng proposal represents a shift from reactive dermatology toward proactive population management. If successful, the model could inform similar strategies in other developing nations with large rural populations and limited specialist density.
Why it matters:
This framework demonstrates how China is moving beyond isolated biomedical breakthroughs to engineer systemic health interventions that match its geographic and demographic realities. For pharmaceutical and diagnostics firms, the plan signals a coming wave of demand for cost-effective, scalable dermatological tools. For public-health researchers worldwide, it offers a blueprint for how large middle-income countries can tackle chronic non-communicable diseases at the grassroots level.
ScientificChina — tracking what’s happening in Chinese science, technology, research, and industrial innovation in a way global professionals can actually use.
Follow ScientificChina for deeper insight into China’s evolving science, technology, and industrial landscape.
No products in the cart.